Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 380

Results For "EU"

5713 News Found

US Federal Court dismisses cancer linkage associated with Zantac
News | December 13, 2022

US Federal Court dismisses cancer linkage associated with Zantac

The current ruling will assure the safety of the use of Ranitidine for Indian patients


Moderna and Merck announce personalized mRNA cancer vaccine
Clinical Trials | December 13, 2022

Moderna and Merck announce personalized mRNA cancer vaccine

Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial


Alembic receives USFDA final Approval for Desonide Cream
Drug Approval | December 12, 2022

Alembic receives USFDA final Approval for Desonide Cream

Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA


Lupin launches generic version of Pennsaid in the US
News | December 12, 2022

Lupin launches generic version of Pennsaid in the US

Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)


Alembic receives EIR for oncology injectable formulation facility at Panelav
Drug Approval | December 12, 2022

Alembic receives EIR for oncology injectable formulation facility at Panelav

This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA


Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
Clinical Trials | December 12, 2022

Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022

Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes


Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData
News | December 12, 2022

Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData

GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.


Emmes launches Cell and Gene Therapy Center
News | December 09, 2022

Emmes launches Cell and Gene Therapy Center

The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies


Samsung Engineering wins work contract from Sartorius for Korean plant
Biotech | December 09, 2022

Samsung Engineering wins work contract from Sartorius for Korean plant

The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters


Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq
Healthcare | December 08, 2022

Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq

Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff